Central Asian Health Leaders Gather in Samarkand to Reinforce Tuberculosis Response Ahead of UN Review
In a high-profile meeting convened by Uzbekistan with technical support from the World Health Organization (WHO), health ministers and senior officials from across Central Asia met in historic Samarkand to coordinate a stronger regional response to tuberculosis (TB). With the United Nations High-Level Meeting on TB in New York approaching, the summit sought to align national strategies, agree on measurable steps, and position Central Asia as a coordinated voice in the global effort to end one of the leading infectious killers worldwide.
Collective Roadmap: Priorities Agreed in Samarkand
Delegations from Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan approved a shared roadmap aimed at accelerating progress toward the WHO End TB targets for 2030. The group emphasized three strategic priorities: widening access to rapid diagnostics, embedding TB services into primary health care, and scaling people-centred support for migrants, workers on the move and other high-risk groups.
- Expand rapid molecular testing closer to communities so cases are detected earlier
- Integrate TB screening and treatment into routine primary care visits
- Design patient-centred pathways that reduce barriers to diagnosis and adherence
Three-Year Regional Action Plan
The summit concluded with a technical communiqué detailing priority actions for the next three years. Key commitments include:
- Interoperable surveillance: build linked systems to monitor cross-border TB and drug-resistant cases in near real time
- Joint procurement: pool purchasing to negotiate lower prices for quality-assured diagnostics and medicines
- Harmonized capacity building: roll out standardized clinical and laboratory training across the region
- Coordinated advocacy: present unified regional priorities at the upcoming UN High-Level Meeting on TB
Country Pledges: National Targets with Regional Impact
| Country | Signed Commitment | Target Year |
|---|---|---|
| Uzbekistan | Nationwide digital reporting of all TB notifications | 2027 |
| Kazakhstan | Universal availability of point-of-care molecular testing | 2026 |
| Kyrgyzstan | TB-HIV integrated services operational in every district | 2027 |
| Tajikistan | Substantially expanded outreach and screening in remote communities | 2028 |
| Turkmenistan | Comprehensive modernization of TB laboratory network | 2027 |
WHO Priorities: Diagnostics, Shorter Regimens and Community Care
WHO representatives at the Samarkand meeting urged governments to commit predictable funding to decentralize diagnostics, adopt modern treatment approaches, and scale up community-led support. According to the WHO Global Tuberculosis Report (2023), roughly 10.6 million people developed TB in 2022 and the disease caused about 1.6 million deaths globally; approximately half a million people developed rifampicin-resistant or multidrug-resistant TB. These figures underscore why rapid testing and effective treatments remain urgent priorities.
Recommended Technical Actions
- Deploy rapid molecular tests (such as cartridge-based assays) widely at the primary care level
- Ensure availability of shorter, better-tolerated regimens for drug-resistant TB where clinically appropriate
- Invest in community health workers and peer-support networks for adherence, tracing and social support
- Include TB services in universal health coverage benefit packages and financing plans
Regional leaders noted pilot programs in several countries where community-delivered care reduced loss to follow-up and lowered out-of-pocket costs for families. Scaling these models, they said, will both improve clinical outcomes and protect vulnerable households from deeper financial hardship.
Strengthening Cross-Border Surveillance and Data Sharing
Experts warned that drug-resistant TB spreads along migration routes and cannot be contained by individual countries alone. The summit proposed developing an interoperable ecosystem for anonymized data exchange-so that resistance trends, diagnostics results and treatment outcomes can be shared quickly and securely across borders. Officials compared this network to an early-warning weather radar for epidemics: the faster you see a storm forming, the sooner you can mobilize a response.
Practical Measures for Regional Protection
- Adopt common case definitions and lab standards to ensure consistency in reporting
- Create legal frameworks that permit ethical data sharing while safeguarding patient privacy
- Establish screening and referral points at major border crossings and transport hubs
- Maintain regional emergency stockpiles of second-line medicines for rapid deployment
- Develop a shared dashboard with near real-time indicators of outbreaks and treatment gaps
| Priority | Current Challenge | Summit Commitment |
|---|---|---|
| Data exchange | Fragmented and delayed reporting | Regional digital alert system by 2027 |
| Border health | Inconsistent screening and referral pathways | Harmonized protocols at key crossings |
| Resistance mapping | Patchy laboratory coverage | Linked reference labs across member states |
Financing, Accountability and Next Steps
Participants acknowledged that pledges must be followed by financing, operational plans and measurable indicators. To move from commitments to measurable impact, the summit recommended that countries:
- Mobilize domestic and international financing tied to specific milestones
- Publish annual progress reports on the regional dashboard to promote transparency
- Invest in workforce retention and laboratory quality assurance
- Engage civil society and people with lived experience in monitoring implementation
Looking Ahead to the UN High-Level Meeting on TB
As delegates prepare to present their consolidated regional position at the United Nations High-Level Meeting on TB in New York, the focus will turn to translating political will into results: wider access to diagnostics, faster initiation of effective treatment, and coordinated cross-border action to stop the spread of drug-resistant strains. The Samarkand summit has put Central Asia’s TB agenda on a collective footing – the real test will be whether these promises are realized on the ground in the coming years.